CrossRef Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus Amanda Hempel Zinglersen, Katrine Kjr Iversen, Henrik Christian Bidstrup Leffers, Esben Laugesen, Jesper Fleischer, Sren Jacobsen Lupus Science & Medicine.2021
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
Due to the increasing use of GLP-1RA in T2DM, the potential impact of adverse effects deserves concern
The most common adverse events reported by those on tirzepatide compared with placebo, respectively, were diarrhea (18.4% vs 6.3%), nausea (17.0% vs 6.5%), and constipation (14.8% vs 6%)
This contrasts with oral tirzepatide formulations, which use absorption enhancers to improve bioavailability